TY - JOUR
KW - Europe
KW - constipation
KW - drug misuse
KW - irritab)
KW - linaclotide
KW - off-label use
AU - J. Cid-Ruzafa
AU - B. Lacy
AU - A. Schultze
AU - M. Duong
AU - Y. Lu
AU - M. Raluy-Callado
AU - R. Donaldson
AU - D. Weissman
AU - A. Gómez-Lumbreras
AU - D. Ouchi
AU - M. Giner-Soriano
AU - R. Morros
AU - A. Ukah
AU - D. Pohl
AD - Evidera, C/ Doctor Trueta 15, 08005, Barcelona, Spain.
Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.
Evidera, London, UK.
Evidera, Stockholm, Sweden.
Allergan, Madison, NJ, USA.
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Cerdanyola del Vallès (Barcelona), Spain.
Allergan, Irvine, CA, USA.
Neurogastroenterology and Motility, Division of Gastroenterology, University Hospital Zurich, Zurich, Switzerland.
AN - 35706826
BT - Therap Adv Gastroenterol
C2 - PMC9189524
DO - 10.1177/17562848221100946
DP - NLM
ET - 2022/06/17
LA - eng
N1 - 1756-2848
Cid-Ruzafa, Javier
Orcid: 0000-0002-1392-6457
Lacy, Brian E
Orcid: 0000-0003-4121-7970
Schultze, Anna
Duong, Mai
Lu, Yi
Raluy-Callado, Mireia
Donaldson, Robert
Weissman, Darren
Gómez-Lumbreras, Ainhoa
Ouchi, Dan
Giner-Soriano, Maria
Morros, Rosa
Ukah, Ahunna
Pohl, Daniel
Journal Article
Therap Adv Gastroenterol. 2022 Jun 11;15:17562848221100946. doi: 10.1177/17562848221100946. eCollection 2022.
PY - 2022
SN - 1756-283X (Print)1756-283x
EP - 17562848221100946
T2 - Therap Adv Gastroenterol
TI - Linaclotide utilization and potential for off-label use and misuse in three European countries
VL - 15
ER -